Taking people in Hong KongNo phase
Screening people with HIV and hepatitis B for hepatitis delta virus
Checks adults with HIV, hepatitis B and liver cancer for hepatitis delta virus.
Plain-language title generated from the registry record
Registry title: HDV Screening Study
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- The Chinese University of Hong KongHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Grace Lai Hung Wong
- Trial code
- NCT06889805
- Record updated
- 24 March 2025
- Original description
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.Read full original descriptionShow less
Universal Screening for Hepatitis Delta Virus (HDV) in Individuals Living with HIV/HBV Coinfection and HBV-related HCC
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
Inclusion: Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND; Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND; Aged 18 years old or above; Written or verbal consent obtained.
Exclusion: Age < 18 years; Refusal to consent.